Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug
Public ClinicalTrials.gov record NCT06641076. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Parallel-group, Randomized, Double-blind, 3-arm, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Subcutaneous Sonelokimab in Male and Female Participants Aged 18 Years and Over With Active Psoriatic Arthritis Who Are Naive to Biologic DMARDs
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study to demonstrate the clinical efficacy and safety of sonelokimab administered subcutaneously compared with placebo in the treatment of adult patients with active psoriatic arthritis who are naive to biologic disease-modifying antirheumatic drug therapy.
Study identification
- NCT ID
- NCT06641076
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 960 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 15, 2024 (Actual)
- Primary completion
- May 28, 2026 (Actual)
- Completion
- Feb 4, 2027 (Estimated)
- Last update posted
- Oct 9, 2026
2024 – 2027
United States locations
- U.S. sites
- 28
- U.S. states
- 13
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Site | Avondale | Arizona | 85392 | — |
| Clinical Site | Chandler | Arizona | 85225 | — |
| Clinical Site | Flagstaff | Arizona | 86001 | — |
| Clinical Site | Mesa | Arizona | 85210 | — |
| Clinical Site | Phoenix | Arizona | 85032 | — |
| Clinical Site | Scottsdale | Arizona | 85260 | — |
| Clinical Site | Tucson | Arizona | 85748 | — |
| Clinical Site | San Diego | California | 92108 | — |
| Clinical Site | Upland | California | 91786 | — |
| Clinical Site | Avon Park | Florida | 33825 | — |
| Clinical Site | Clearwater | Florida | 33765 | — |
| Clinical Site | Hialeah | Florida | 33016 | — |
| Clinical Site | Tampa | Florida | 33607 | — |
| Clinical Site | Springfield | Illinois | 62702 | — |
| Clinical Site | Lake Charles | Louisiana | 70605 | — |
| Clinical Site | Baltimore | Maryland | 21224-6821 | — |
| Clinical Site | Grand Blanc | Michigan | 48439-2451 | — |
| Clinical Site | Leland | North Carolina | 28451 | — |
| Clinical Site | Salisbury | North Carolina | 28144 | — |
| Clinical Site | Statesville | North Carolina | 28625 | — |
| Clinical Site | Middleburg Heights | Ohio | 44130 | — |
| Clinical Site | Portland | Oregon | 97239 | — |
| Clinical Site | Memphis | Tennessee | 38119 | — |
| Clinical Site | Allen | Texas | 75013 | — |
| Clinical Site | Colleyville | Texas | 76034 | — |
| Clinical Site | Lubbock | Texas | 79424 | — |
| Clinical Site | Plano | Texas | 75024 | — |
| Clinical Site | Beckley | West Virginia | 25801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 154 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06641076, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 9, 2026 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06641076 live on ClinicalTrials.gov.